ASMB Projected Dividend Yield
Assembly Biosciences Inc ( NASDAQ : ASMB )Assembly Biosciences is a biotechnology company developing clinical candidates for the treatment of chronic hepatitis B virus (HBV) infection, an early-stage development program targeting high-recurrence genital herpes and research programs focused on the discovery of novel antivirals to treat viral diseases, including hepatitis delta virus (HDV), herpes simplex virus type 2 and transplant related herpesviruses. Co.'s HBV and HDV programs include: Core Inhibitors, which consist of 3733 and 4334; HBV/HDV Entry Inhibitor, which focuses on an orally bioavailable small molecule approach to inhibit entry of HBV and HDV; and IFNAR Agonist. 20 YEAR PERFORMANCE RESULTS |
ASMB Dividend History Detail ASMB Dividend News ASMB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |